Microbiome Sequencing Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Microbiome Sequencing Market: By Technology (Shotgun Sequencing, Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), Targeted Gene Sequencing Others) Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology Other) Research Type (Outsourced Research, Internal Research) End User (Pharmaceutical and Biotechnology Companies, Academia/Research Institutes, Contract Research organizations) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Microbiome Sequencing Market Introduction
2.1. Global Microbiome Sequencing Market – Taxonomy
2.2. Global Microbiome Sequencing Market –Definitions
2.2.1. Technology
2.2.2. Application
2.2.3. Research Type
2.2.4. End User
3. Global Microbiome Sequencing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Microbiome Sequencing Market Dynamic Factors – Impact Analysis
3.6. Global Microbiome Sequencing Market – Competition Landscape
4. Global Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Microbiome Sequencing Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Shotgun Sequencing
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Sequencing by Synthesis (SBS)
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Sequencing by Ligation (SBL)
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Targeted Gene Sequencing
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Microbiome Sequencing Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Gastrointestinal Diseases
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Infectious Diseases
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. CNS Diseases
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Oncology
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Microbiome Sequencing Market, By Research Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Outsourced Research
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Internal Research
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Microbiome Sequencing Market, By End User Industry, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Academia/Research Institutes
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Contract Research organizations
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Microbiome Sequencing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Region, 2022-2028
10. North America Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Shotgun Sequencing
10.1.2. Sequencing by Synthesis (SBS)
10.1.3. Sequencing by Ligation (SBL)
10.1.4. Targeted Gene Sequencing
10.1.5. Others
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Gastrointestinal Diseases
10.2.2. Infectious Diseases
10.2.3. CNS Diseases
10.2.4. Oncology
10.2.5. Other
10.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Outsourced Research
10.3.2. Internal Research
10.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academia/Research Institutes
10.4.3. Contract Research organizations
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
10.7. North America Microbiome Sequencing Market Dynamics – Trends
11. Europe Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Shotgun Sequencing
11.1.2. Sequencing by Synthesis (SBS)
11.1.3. Sequencing by Ligation (SBL)
11.1.4. Targeted Gene Sequencing
11.1.5. Others
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Gastrointestinal Diseases
11.2.2. Infectious Diseases
11.2.3. CNS Diseases
11.2.4. Oncology
11.2.5. Other
11.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Outsourced Research
11.3.2. Internal Research
11.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academia/Research Institutes
11.4.3. Contract Research organizations
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
11.7. Europe Microbiome Sequencing Market Dynamics – Trends
12. Asia-Pacific Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Shotgun Sequencing
12.1.2. Sequencing by Synthesis (SBS)
12.1.3. Sequencing by Ligation (SBL)
12.1.4. Targeted Gene Sequencing
12.1.5. Others
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Gastrointestinal Diseases
12.2.2. Infectious Diseases
12.2.3. CNS Diseases
12.2.4. Oncology
12.2.5. Other
12.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Outsourced Research
12.3.2. Internal Research
12.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academia/Research Institutes
12.4.3. Contract Research organizations
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
12.7. Asia-Pacific Microbiome Sequencing Market Dynamics – Trends
13. Latin America Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Shotgun Sequencing
13.1.2. Sequencing by Synthesis (SBS)
13.1.3. Sequencing by Ligation (SBL)
13.1.4. Targeted Gene Sequencing
13.1.5. Others
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Gastrointestinal Diseases
13.2.2. Infectious Diseases
13.2.3. CNS Diseases
13.2.4. Oncology
13.2.5. Other
13.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Outsourced Research
13.3.2. Internal Research
13.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academia/Research Institutes
13.4.3. Contract Research organizations
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
13.7. Latin America Microbiome Sequencing Market Dynamics – Trends
14. Middle East and Africa Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Shotgun Sequencing
14.1.2. Sequencing by Synthesis (SBS)
14.1.3. Sequencing by Ligation (SBL)
14.1.4. Targeted Gene Sequencing
14.1.5. Others
14.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Gastrointestinal Diseases
14.2.2. Infectious Diseases
14.2.3. CNS Diseases
14.2.4. Oncology
14.2.5. Other
14.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Outsourced Research
14.3.2. Internal Research
14.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Academia/Research Institutes
14.4.3. Contract Research organizations
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
14.7. MEA Microbiome Sequencing Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Technologies, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Baseclear BV
15.2.2. Clinical Microbiomics AS
15.2.3. Merieux Nutrisciences Corporations
15.2.4. EPIBIOME
15.2.5. Microbiome Insights Inc
15.2.6. Microbiome Therapeutics LLC
15.2.7. MR DNA
15.2.8. Second Genome
15.2.9. Ubiome Inc.
15.2.10. Clear Labs
16. Research Methodology
17. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Baseclear BV
  • Clinical Microbiomics AS
  • Merieux Nutrisciences Corporations
  • EPIBIOME
  • Microbiome Insights Inc
  • Microbiome Therapeutics LLC
  • MR DNA
  • Second Genome
  • Ubiome Inc.
  • Clear Labs

Description

1. Executive Summary
2. Global Microbiome Sequencing Market Introduction
2.1. Global Microbiome Sequencing Market – Taxonomy
2.2. Global Microbiome Sequencing Market –Definitions
2.2.1. Technology
2.2.2. Application
2.2.3. Research Type
2.2.4. End User
3. Global Microbiome Sequencing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Microbiome Sequencing Market Dynamic Factors – Impact Analysis
3.6. Global Microbiome Sequencing Market – Competition Landscape
4. Global Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Microbiome Sequencing Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Shotgun Sequencing
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Sequencing by Synthesis (SBS)
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Sequencing by Ligation (SBL)
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Targeted Gene Sequencing
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Microbiome Sequencing Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Gastrointestinal Diseases
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Infectious Diseases
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. CNS Diseases
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Oncology
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Microbiome Sequencing Market, By Research Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Outsourced Research
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Internal Research
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Microbiome Sequencing Market, By End User Industry, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Academia/Research Institutes
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Contract Research organizations
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Microbiome Sequencing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Region, 2022-2028
10. North America Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Shotgun Sequencing
10.1.2. Sequencing by Synthesis (SBS)
10.1.3. Sequencing by Ligation (SBL)
10.1.4. Targeted Gene Sequencing
10.1.5. Others
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Gastrointestinal Diseases
10.2.2. Infectious Diseases
10.2.3. CNS Diseases
10.2.4. Oncology
10.2.5. Other
10.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Outsourced Research
10.3.2. Internal Research
10.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academia/Research Institutes
10.4.3. Contract Research organizations
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
10.7. North America Microbiome Sequencing Market Dynamics – Trends
11. Europe Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Shotgun Sequencing
11.1.2. Sequencing by Synthesis (SBS)
11.1.3. Sequencing by Ligation (SBL)
11.1.4. Targeted Gene Sequencing
11.1.5. Others
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Gastrointestinal Diseases
11.2.2. Infectious Diseases
11.2.3. CNS Diseases
11.2.4. Oncology
11.2.5. Other
11.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Outsourced Research
11.3.2. Internal Research
11.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academia/Research Institutes
11.4.3. Contract Research organizations
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
11.7. Europe Microbiome Sequencing Market Dynamics – Trends
12. Asia-Pacific Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Shotgun Sequencing
12.1.2. Sequencing by Synthesis (SBS)
12.1.3. Sequencing by Ligation (SBL)
12.1.4. Targeted Gene Sequencing
12.1.5. Others
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Gastrointestinal Diseases
12.2.2. Infectious Diseases
12.2.3. CNS Diseases
12.2.4. Oncology
12.2.5. Other
12.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Outsourced Research
12.3.2. Internal Research
12.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academia/Research Institutes
12.4.3. Contract Research organizations
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
12.7. Asia-Pacific Microbiome Sequencing Market Dynamics – Trends
13. Latin America Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Shotgun Sequencing
13.1.2. Sequencing by Synthesis (SBS)
13.1.3. Sequencing by Ligation (SBL)
13.1.4. Targeted Gene Sequencing
13.1.5. Others
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Gastrointestinal Diseases
13.2.2. Infectious Diseases
13.2.3. CNS Diseases
13.2.4. Oncology
13.2.5. Other
13.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Outsourced Research
13.3.2. Internal Research
13.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academia/Research Institutes
13.4.3. Contract Research organizations
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
13.7. Latin America Microbiome Sequencing Market Dynamics – Trends
14. Middle East and Africa Microbiome Sequencing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Shotgun Sequencing
14.1.2. Sequencing by Synthesis (SBS)
14.1.3. Sequencing by Ligation (SBL)
14.1.4. Targeted Gene Sequencing
14.1.5. Others
14.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Gastrointestinal Diseases
14.2.2. Infectious Diseases
14.2.3. CNS Diseases
14.2.4. Oncology
14.2.5. Other
14.3. Research Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Outsourced Research
14.3.2. Internal Research
14.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Academia/Research Institutes
14.4.3. Contract Research organizations
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Microbiome Sequencing Market – Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2022-2028
14.7. MEA Microbiome Sequencing Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Technologies, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Baseclear BV
15.2.2. Clinical Microbiomics AS
15.2.3. Merieux Nutrisciences Corporations
15.2.4. EPIBIOME
15.2.5. Microbiome Insights Inc
15.2.6. Microbiome Therapeutics LLC
15.2.7. MR DNA
15.2.8. Second Genome
15.2.9. Ubiome Inc.
15.2.10. Clear Labs
16. Research Methodology
17. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX